Abstract
Extracellular vesicles (EVs) from human Explant-Derived Cells delivered directly to the atria at the time of open chest surgery reduce atrial fibrosis/inflammation and AF in a rat model of sterile pericarditis. But the minimally effective dose is not known, nor is it clear if this benefit is dependent on EV dose.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
